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All humans are colonized by a vast diversity of microbes (bacteria, archaea, protozoa,
yeast, and fungi; collectively referred to as the microbiota) and viruses (the virobiota).
This latter group includes viruses infecting prokaryotic cells (bacteriophages), viruses
infecting eukaryotic-host cells, and virus-derived genetic elements present in host
chromosomes. Although these eukaryotic viruses are mostly known to be pathogens,
they are also able to establish mutualistic relationships with humans. Little is known
about the mutualistic aspects of viral infection. Nevertheless, it is clear that evolution
of some animal virus-host interactions has led to benefits in the health of the hosts, as
is the case with symbiogenesis and endogenization of retroviruses that has exerted
a neuroprotective effect on the human brain, and an important role in the fetal
development, thus on the evolution of host species. In this review, we summarize
how retroviruses provide amazing examples of cooperative-evolution, i.e., successful
exchange between viruses and host, and how, in some cases, the benefits have become
essential for the hosts’ survival.
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INTRODUCTION
Recent metagenomics studies have revealed that, not only is the human body colonized by
microorganisms belonging to all three biological domains (i.e., Eukarya, Archaea, and Bacteria),
but that the human microbiota is also composed of many viruses (Handley et al., 2012; Duerkop
and Hooper, 2013). As such, the term “microbiota” also comprises the term “virobiota,” a huge
community of viruses that science has only just begun to explore and whose physiological roles
are still unknown (White et al., 2012; Figure 1A). The viruses present in the human virobiota are
bacteriophages (infecting bacteria) and eukaryotic viruses, which replicate in animal cells or that
infect plants associated with the host’s diet. Thanks to the presence of this last category of viruses
the virobiota is considered a dynamic community that varies based on what each of us eats and
where we live (Freer et al., 2018). While we might consider some bacteriophages as stable residents
of the human body, since they infect the bacteria that stably colonize the human host (Allen and
Abedon, 2013), the situation is quite different with regard to eukaryotic viruses. In this latter case,
metagenomic studies have found it very difficult to discriminate truly resident viruses associated
with the host from viruses whose presence is due to acute (e.g., influenza virus), chronic (e.g.,
hepatitis B virus), or latent infections (e.g., herpesvirus) (Duerkop and Hooper, 2013).
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According to the canonical definition, viruses are parasites
associated with negative consequences; in other words,
pathogenic viruses cause diseases in the human host, who
either survives or dies as a consequence (e.g., influenza virus,
rabies virus, and measles virus). Only recently, has it been shown
that among the 220 viruses able to infect humans, only about
100 are pathogenic (Parker, 2016). The remainder is composed
of apathogenic viruses that establish commensal or symbiotic
interactions with host (Figure 1A). To the best of our knowledge,
anelloviruses (AV) could provide the prototypical example of a
human commensal virus and are also a major component of the
virobiota. This virus family includes a group of single stranded
DNA-viruses, newly discovered (in 1997), that are present in
both the blood and tissues of most humans, where they replicate
persistently without causing disease (Freer et al., 2018).
A key example of a symbiotic virus-host relationship, on the
other hand, is provided by the human endogenous retroviruses
(HERVs). A symbiotic interaction is a form of mutualism
whereby both virus and the human host gain benefits from
their relationship (Figure 1A). More specifically, HERVs are
primary symbionts because the viruses, after infecting germ cells,
are transmitted vertically from parent to child (Parker, 2016).
Although some evidence exists indicating that HERVs could
contribute to the insurgence of certain pathologies [e.g., multiple
sclerosis (MS), carcinogenesis, or bipolar disorder; Antony et al.,
2004; Galli et al., 2005], in this review, we will focus on the
beneficial effects of HERVs on humans. HERVs in fact provide
an excellent example of how a “negative” event, such as a viral
infection, can have a positive impact on the host’s biology,
establishing a successful interaction with it.
HUMAN ENDOGENOUS RETROVIRUSES
(HERVs)
Data provided by the Human Genome Project suggest that the
most abundant repetitive class of human DNA sequences is
made up of distinct families of transposable elements (about 46–
47% of human genome), of which 2–3% correspond to DNA
transposons and 42–43% to retroelements (Smit, 1999). Based
on the presence or absence of a long terminal repeat (LTR),
retroelements are then divided into two large groups: non-LTR
retroelements (corresponding to 33% of the human genome) and
including LINEs (long interspersed nuclear elements) and SINEs
(short interspersed nuclear elements) (Larsson and Andersson,
1998), and LTR-containing viral retroelements (around 8% of
the human genome) that consist of HERV and retrotransposons,
which differ from each other by the presence/absence of env gene
(Figure 1B; Nelson et al., 2004).
Human endogenous retroviruses represent therefore a group
of transposable elements that were originally acquired through
the exogenous infection of primate hosts by ancestor retroviruses
over the course of primate evolution (Katzourakis et al., 2009;
Hayward et al., 2015), i.e., between 5 and 70 million years ago
(Aiewsakun and Katzourakis, 2015). In contrast with exogenous
retroviruses that are horizontally transmitted between hosts and
usually associated with disease, HERVs infections have affected
both somatic cells and germ-lines. Hence, following an occasional
process of endogenization and further fixation, through which
viral DNA copies permanently integrated into the host’s germ-
line chromosomes, HERVs were vertically transmitted to progeny
in a Mendelian fashion, determining their coevolution with the
host genome (Katzourakis et al., 2009; Lee et al., 2013). As
such, once endogenized, HERVs retain their similarities with the
ancestral exogenous virus for an exceedingly long time (millions
of years) since they incur point mutations at the same rate of the
host, about 10−9 substitutions per site per year (s/n/y) instead
of a virus’s rate of 10−3 s/n/y (Hanada et al., 2004; Sanjuán,
2012). Ancestral HERVs integrated into the human genome
around 35–45 million years ago, during the split between Old and
New World monkeys (Bannert and Kurth, 2006). Only HERV-
K viruses are the most recently integrated group (occurring ˜5
million years ago); they are exclusive to humans and contain the
most complete proviral sequences.
Human endogenous retroviruses have a genomic organization
similar to that of the exogenous retroviruses, composed of
the viral genes gag, pro-pol, and env, flanked by two LTRs
(Figure 2A). LTRs are formed during the reverse transcription
of the viral RNA genome and regulate the viral genes’ expression
due to the presence of promoters, enhancers, and polyadenylation
signals (Schön et al., 2009; Vargiu et al., 2016). The gag gene
encodes three structural virion components: the matrix (MA),
capsid (CA), and nucleocapsid (NC) proteins. The pol gene
encodes two enzymes necessary for the viral life cycle: reverse
transcriptase/integrase (pol) and protease (pro), which synthesize
the complementary DNA from the viral RNA and enable
proviral integration. The env gene encodes two envelope proteins:
transmembrane protein (TM) and surface protein (SU) (Larsson
and Andersson, 1998), which mediate virus entry into and egress
from host cells.
Human endogenous retroviruses can sometimes harbor more
than these four retroviral genes, like type I HERV-K, whose env
gene gives rise to two splice variants: the accessory proteins
Np9 and Rec (Armbruester et al., 2002; Grandi et al., 2017),
or type II HERV-K with Sp and Rec (Ruggieri et al., 2009;
Douville and Avindra, 2014). Between the 5′LTR and gag, a
primer-binding site (PBS) is located, and a polypurine trait
(PPT) lies between env and the 3′LTR. Both these sequences
localized between the LTRs exert important functions: the
cellular tRNA becomes bound to the PBS during the reverse
transcription process, whereas the PPT is the primer for (+)
strand DNA production. Moreover, the PBS sequence has
traditionally been used for a systematic nomenclature of HERV,
since HERV group names are generally identified using a letter
that characterizes the human tRNA type that binds to the viral
PBS sequences during the retrotranscription process of the viral
genome (e.g., HERV-K for lysine, HERV-W for tryptophan,
etc.). If the PBS sequence is not available, HERV groups are
also named according to unconventional criteria, such as the
name of a neighboring gene (HERV-ADP), a clone number
(e.g., HERV-S71), or a particular amino acid motif (HERV-
FRD) (Werner et al., 1990; Lyn et al., 1993; Seifarth et al.,
1995). However, this characterization of the HERV groups at
the genomic level is considered inadequate and incomplete
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FIGURE 1 | (A) Human microbiota and virobiota. The green circle contains the components of the microbiota (Bacteria, Archea, and Eukaria), while the blue-light
contains all the members of the virobiota (bacteriophages, eukaryotic viruses), which in turn is included in the microbiota (on left). Types of dynamic interaction
between microorganisms and human-host: the community can shift from parasitism to mutualism and commensalism, favoring an improved state of health; on the
contrary if microorganisms shift toward parasitism, they favor the disease (on right). (B) Repetitive mobile sequences present in human genome: almost half of
genome is made up by transposable elements: DNA transposons (2–3%) and retroelements (42%). The former amplifies without RNA, the latter requires a reverse
transcriptase.
because univocal guidelines for the naming of groups are missing
(Grandi and Tramontano, 2018b). Recently, a new multi-step
approach based on a phylogenetic study (considering the highly
conserved pol gene) and univocal taxonomic rules allowed the
splitting up of about 3200 HERV insertions, identified using
the RetroTector program (ReTe) (Sperber et al., 2007), into
39 “canonical” groups plus other 31 “non-canonical” clades
(Vargiu et al., 2016). Nonetheless, conventional classification
also divides each HERV group into three classes according
to sequence homology with exogenous retroviruses: class I
(Gammaretrovirus- and Epsilonretrovirus-like: HERV-E, -F, -H,
-I, -P, -R, -T, -W, and HERV-FRD, etc.); class II (Betaretrovirus-
like: HERV-K); and class III (Spumaretrovirus-like: HERV-L)
(Larsson and Andersson, 1998).
Hosts infected by HERVs can adopt various strategies
to repress the viral replication and prevent the horizontal
transmission of infections between individuals, such as viral
genome silencing through epigenetic regulation mechanisms
(DNA methylation) or the association of histones to viral
DNA to limit its accessibility to the proteins involved in gene
transcription (Grandi and Tramontano, 2018b). When viral DNA
is integrated into the human host genome, it can undergo
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FIGURE 2 | (A) Genomic organization of an endogenous retrovirus. The integrated double-stranded DNA is characterized by the long terminal repeats (LTRs) at its 5′
and 3′ ends. LTRs flank the retroviral gag, pro/pol, and env genes. (B) Schematization of the beneficial effects of HERVs to human host.
over time recombination events leading to the formation of a
solitary LTR, or to insertions, deletions, and mutations, thus
inactivating the ability of HERVs to produce infectious viruses.
In this regard, one of the more ancient components of the
cellular machinery that confer intrinsic immunity against mobile
elements is represented by the APOBEC cytidine deaminases.
Among these cellular enzymes, members of the APOBEC3
(A3) protein family induce G-to-A hypermutations in HERV
genomes, thus leading to suppression of HERV replication and its
mobility in favor of the host’s genomic integrity (Ito et al., 2020).
However, as we will see, this is not always the case, because
several HERVs have been co-opted into physiological functions
of the host, with some members being actively transcribed and
differentially expressed depending on host cell type and the
physiological circumstances (Figure 2B).
HERV AND THE PLACENTA
In some cases, retroviral genes are recycled since they confer an
advantage to the host: the most famous examples are syncytin-
1 and syncytin-2. Syncytin-1 and -2 are functional glycoproteins
that mediate cell-cell fusion between cytotrophoblasts and
placental syncytiotrophoblasts localized at the fetomaternal
interface, which plays a fundamental role in the exchange of
nutrients, hormones, and gases between the mother and the
fetus and is required for normal embryonic growth (Muyan and
Boime, 1997; Handwerger and Freemark, 2000). Additionally,
syncytiotrophoblasts keep the maternal immunosuppressive state
under control, preventing fetal rejection (Munoz-Suano et al.,
2001; Nakamura, 2009). It has been known for some years that
the syncytin-1 sequence is homologous to that of the env gene
of the complete HERV-W provirus (Perron et al., 2005); whereas
syncytin-2 corresponds with the HERV-FRD-env gene.
It is probable that the syncytin proteins of retroviruses
enable membrane fusion with host cells, facilitating viral
infection. This function has been “commandeered” in placental
mammals as it makes the placenta more invasive toward the
maternal uterus, thus conveying an evolutionary advantage to
the embryo. Similarly to other retroviral glycoproteins, syncytin-
1 and syncytin-2 are synthesized as precursors that only become
functional after their cleavage into two functional subunits: SU
(involved in cellular receptor binding) and TM (involved in cell-
cell fusion). Both proteins also harbor an immunosuppressive
domain (ISD) that, as mentioned above, is required for generating
the fetomaternal tolerance state during pregnancy, although
the molecular mechanisms involved in the modulation of the
immune response are not known (Lokossou et al., 2014).
High expression of HERV-R (class I retrovirus) also helps
protect the fetus from the maternal immune response. In fact, its
expression results in elevated concentrations of env protein that
is potentially immunosuppressive. A direct correlation has been
identified between the expression levels of fusogenic syncytin-1
and -2 and preclampsia (or gestosis) events, since both proteins
levels were shown to be decreased in preclampsia following
hypermethylation in the 3′LTR (Vargas et al., 2011). Considering
this strong correlation, these HERV proteins could be used as
potential markers for the early diagnosis of preclampsia.
In addition to this known function in placentation in
mammals, a recent study has shown that syncytin also supports
myogenesis, increasing muscle mass in male mice (Redelsperger
et al., 2016). In fact, deletion of the syncytin B isoform led to a
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20% reduction in muscle mass in knockout mice compared with
animals with both syncytin A and syncytin B. This reduction was
male-specific because not visible in female. As suggested by the
authors of the study, syncytin B could play a decisive role in the
muscular development of male mice, and its role may explain the
muscle sexual dimorphism observed in all placental mammals
(Redelsperger et al., 2016).
HERV AND BRAIN PROTECTION
A number of HERVs (e.g., -W, -K, -R, and -E) are expressed
in human brain tissues (Antony et al., 2006, 2007), but a
neuroprotective function was only ascribed to class II HERV-
K env gene. In fact, deep transcriptomic sequencing analyses
revealed significantly greater HERV-K expression in healthy fetal
brain than all other HERVs (Bhat et al., 2014). Using an in vitro
paradigm, the same study showed that transfection of the human
neuronal cell line (SK-N-SH) with an HERV-Kenv expression
plasmid enhanced the transcription of the neurotrophins nerve
growth factor (NGF) and brain-derived neurotrophic factor
(BDNF) compared with cells transfected with a control construct
(pGFP). Both these neurotrophins contribute toward the growth
and survival of developing neurons and to the maintenance
of neuronal function (Bhat et al., 2014). Indeed, it has been
proposed that their depletion might lead to the development
of CNS disorders (Allen et al., 2013). Bhat and colleagues also
showed HERV-K env to confer neurotrophic effects on neuronal
cells exposed to neurotoxins, as observed in murine NG108
neuronal cells transfected with pHERV-Kenv and treated with
different neurotoxins, staurosporine and HIV-1 Vpr protein, in
which the cellular viability reached 100 and 60%, respectively, in
response to the treatment. These results substantiate a beneficial
effect of HERV-K on neuronal cells by preventing neuronal
injury mediated by these two neurotoxins (Bhat et al., 2014).
A neuroprotective effect of HERV-K was also demonstrated
in vivo by means of a neurobehavioral study performed with
immunodeficient HIV-vpr/ RAG1−/− mice able to express the
neurotoxic Vpr protein. For this experiment, neuronal stem cells
(NSCs) were transfected with pHERV-K env or pGFP, as control,
and then implanted into the striatum of the animals. In line
with the results of the in vitro experiment, NSCs cells expressing
HERV-K env protein showed high levels of BDNF without
any changes in neuronal morphology or density. Moreover,
diminished tumor necrosis factor alpha (TNFα) expression (a
well-known toxic factor) was observed together with reduced
neuroinflammation. Striatal function was also evaluated by
assessing the rotational behavior of the animals caused by a
lesion resulting from the unilateral intrastriatal injection of
amphetamine (Bhat et al., 2014). To summarize briefly, following
the induced neurological injury, mice would exhibit ipsiversive
movement toward the side of the lesion; in terms of their rotary
behavior, the mice implanted with pHERV-K env-transfected
cells exhibited reduced neurobehavioral deficits respect to mice
implanted with the control construct. The results of this in vivo
experiment strengthen the in vitro data obtained so far on the
neuroprotective properties exerted by HERV-K env.
HERV AND HORMONE-DEPENDENT
ORGANS
Another possible role of HERV env-encoded proteins could
be their involvement in the maturation and functional activity
of steroid-dependent organs. As in the case of the placenta,
HERV-R expression is particularly high during fetal development
and it is thought to be engaged in embryogenesis (Andersson
et al., 2002). A previous study conducted on three developing
fetuses (5–6 weeks) demonstrated an organ-specific expression
of HERV-R, since high levels of HERV-R env mRNA in the
secretary epithelium of the gut, the kidneys, the tongue, the
heart, the liver, and the central nervous system, but not in
the epidermidis were observed. However, the highest level of
expression was demonstrated in the placenta and in the adrenal
cortex (Andersson et al., 2002). In the latter case, env protein was
also detected using immunofluorescence in a postpartum fetus.
This expression may be controlled by the presence of androgens
that regulate HERV-R expression, since this retrovirus contains
androgen receptor (AR) sites in its 5′LTR (Kato et al., 1987).
In fact, it is known that about half way through pregnancy
the adrenal cortex secretes androgens necessary for the growth
and development of the fetus (O’Rahilly, 1983), which, could,
in turn, bind to the retroviral AR sites. Moreover, since high
levels of HERV-R have also been reported in human adult
adrenal cortex (Katsumata et al., 1998), we might suppose that
env expression is constitutive and not limited to embryogenesis
period. Although a role remains to be established in human adult,
the most accredited hypothesis is that HERV-R could be involved
in protecting the fetus and newborn against further retroviral
infections through the mechanism of receptor interference. In
fact, since the sebum makes up part of the vernix caseosa that
covers the fetus’s skin, it is possible that the presence of HERV-
R env protein in this secretion is able to prevent a viral infection
by blocking the corresponding receptor (Andersson et al., 1996).
This hypothesis may be reasonable for female subjects, but
a potential function of HERV-R env expression in steroid
hormone-dependent male organs remains to be discovered.
HERV AND ANTIVIRAL ACTIVITY
During viral infections, host cells activate different restriction
factors, coping with such infections. In the context of
exogenous retrovirus infections, more than nine groups of
cellular restriction factors have been reported to interfere with
Human Immunodeficiency Virus type 1 (HIV-1) replication.
They include the well-characterized APOBEC3G, SAMHD1,
Tetherin/BST-2, and TRIM5α proteins (Johnson, 2013), and
those more recently characterized such as MX-2, SERINC3/5,
IFITMs, Schlafen 11, and MARCH2/8 (Goujon et al., 2013;
Zhang et al., 2018). Relevant to this, endogenized HERVs can
be potentially considered per se as restriction factors able to
exert protective effects against exogenous retroviruses (Grandi
and Tramontano, 2018a). Three possible mechanisms have
been suggested by which HERV could promote resistance
to exogenous retrovirus infections: (1) Occurrence of
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complementary interactions between HERV mRNAs and
homologous RNAs originated by exogenous retrovirus, with
formation of dsRNA molecules that, in turn, can stimulate
the Toll-Like Receptor 3 (TLR3) and thus an innate immune
response (Zhou et al., 2010). (2) Aggregation of HERV and
retroviral proteins, as observed in cells co-infected by both HIV-1
and HERV-K, in which gag proteins of both viruses colocalized
at the plasma membrane and co-assembly into the same HIV-
1 virions, thus inhibiting release of new HIV-1 infectious
particles (Monde et al., 2017). (3) Superinfection interference,
as that exerted by HERV pseudo-viral particles or HERV-derived
proteins that block retrovirus entry through cellular-receptor
interference. This was the case of the truncated HERV-F env
protein (lacking the TM subunit) encoded by the suppressyn gene,
that by binding the cell receptor ASCT2 could prevent the entry
of several type D-retroviruses (Sugimoto et al., 2013).
Eventually, a negative effect of the full-length HERV-K 108 env
protein was observed in vitro on the release of infectious HIV-1
virions production, albeit further studies are needed to elucidate
the underlying molecular mechanism, it seems that it does not
belong to any of the above described (Terry et al., 2017).
However, despite the above in vitro observations, there is not
yet direct evidence that the 30 env genes found in the human
genome confer resistance to retroviruses in vivo (Johnson, 2013).
CONCLUSION
Human endogenous retroviruses are an integral part of the
human genome and result from ancestral infections by their
exogenous progenitors of cells of the human germline, where
they have undergone replication together with host genes.
Theoretically, the presence of these viral sequences could be
potentially harmful for the host because their integration could
lead to mutations. However, HERVs were not eliminated during
evolution, but rather they were maintained in the host-genome.
If, in the past, HERVs were mistakenly considered as useless
elements of the human genome (DNA junk), today some are
recognized as conferring biological advantages. In fact, in some
cases, HERV genomes have undergone a process of positive
selection during evolution, being exploited by the hosts to benefit
important physiological processes.
As we have summarized in this review, HERVs appear to play
important roles in physiology, fetal development, and human
evolution: if the accidental infection of a mammalian ancestor by
an exogenous retrovirus had never occurred, the placenta and the
mammals that produce it, including humans, would never have
existed. These beneficial consequences can explain why HERVs
have been “fixed” into the genome instead of being eliminated
over the years. Nevertheless, the endogenization of retroviruses
was not without consequences: during evolution, the majority
of HERVs accumulated deletions and mutations that generally
compromised their ability to replicate and produce proteins
unless under specific conditions. This was the price to be paid
for their survival. In this review, we have reported on current
findings regarding the biological advantages that HERVs confer
to humans. Indeed, endogenous retroviruses provide a perfect
example of a symbiotic relationship between a virus and its host,
yet a profound understanding of HERV biology that could lead
to a better comprehension of their roles is still missing. However,
some HERVs are also compatible with parasitic relationship. In
fact, various studies have highlighted an association between the
presence of HERVs, probably those that have integrated into
human genome more recently, and some rare and incurable
diseases, in particular autoimmune, neurodegenerative, and
cancer diseases (Antony et al., 2004; Grandi and Tramontano,
2017, 2018a; Ibba et al., 2018). These findings are highly relevant
because, if a clear evidence emerges that HERVs are explicitly
involved in the onset of these pathologies, this would open up
new treatment prospects, as they would no-longer be considered
incurable diseases, but as pathologies involving one or more
retroviruses against which antiretroviral therapies could be used
or developed. Indeed, this knowledge would pave the way to
important new therapeutic approaches for the treatment of
such pathologies.
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